Mike Hennessy, Sr.


Keeping Hope in Your Back Pocket as a Patient With Cancer

October 25, 2021

When a patient’s disease stops responding, doctors can usually offer patients several options for a next treatment that will accommodate the patient’s needs and goals, or patients can consider a clinical trial.

Questions Linger Around COVID-19’s Origin

June 29, 2021

We may never know what triggered the global pandemic that has claimed more than 3.8 million lives. And we won’t know the long-term effects until enough time has elapsed. What we do know for certain is that the incredible strength and collaboration of the scientific community have allowed us to regain some semblance of normalcy.

You May Have Second Thoughts When Receiving a Cancer Diagnosis

May 07, 2021

Luckily, obtaining a second opinion has become easier with advances in telehealth and other virtual technologies, which allow patients to share their medical records and test results with physicians and pathologists to potentially improve treatment plans.

The Different Roads of Lung Cancer

May 03, 2021

We all handle things differently, look at things differently and understand differently, meaning that the journey of each patient with cancer is unique. But there are always similarities among the symptoms, risks and treatments.

Too Few Recognize the Dangers of a Common Skin Cancer: Squamous Cell Carcinoma

October 21, 2019

Cutaneous squamous cell carcinoma, caused by sun exposure or environmental toxins, is usually curable with surgery. Maybe that’s why many don’t realize that, if this cancer goes unchecked and untreated, it can grow, spread and become life-threatening.

Minimally Invasive Treatments Let Patients Feel Better Faster

October 16, 2019

We hope the information shared in these pages will be helpful to readers across the genitourinary cancer landscape, offering insights into the myriad treatments available and the issues to consider when choosing a therapeutic path.

Immuno 101

September 30, 2019

In this special issue of CURE®, we take a walk through history, from revisiting the major medical milestones of immunotherapy to reviewing how far it has come in cancer treatment.

To Improve Quality of Life and Health Outcomes, Seek Supportive Care

August 22, 2019

When cancer centers emphasize supportive care, patients, survivors and their families benefit and health outcomes can even improve. In this issue of CURE®, we take you inside a facility dedicated to this kind of care — The Supportive Care Center at The University of Texas MD Anderson Cancer Center in Houston.

Closing the Door on Cancer Care Debt

August 13, 2019

It’s no surprise that cancer care comes with a large price tag. However, it’s not always obvious at the time of treatment how much the disease, its management and the lasting effects will financially affect someone well into survivorship.

Despite Her Unique 'Previvorship' Experience, One Woman Shares Universal Truths

May 22, 2019

"We hope that this array of articles, while offering comprehensive information about cutting-edge treatments, will also serve as a reminder of the shared experience of those in the cancer community and the sense of connection it can bring," said Chairman and CEO, Mike Hennessy, Sr.

Take a Mental Break: Psychosocial Issues and Women's Cancers

March 27, 2019

Mike Hennessy, Sr., Chairman and CEO, discusses psychosocial issues associated with women's cancers — the mental, emotional, social and spiritual effects of cancer that occur at diagnosis, during treatment and throughout life after the disease.

MJH Associates Is Proud to Bring CURE Magazine to Canadian Readers

January 11, 2019

With a mission of informing and inspiring the many people affected by cancer, we at CURE® magazine enjoy the proud task of reporting advances in the understanding and treatment of this deeply complex group of diseases.

Finding Inspiration in the Progress and Insights CURE

December 25, 2018

Bringing you the perspectives of those on the cancer journey is something we especially like to do in our annual bonus issue, as the holidays and the year’s end offer opportunities for reflection.

Living Stronger With Lung Cancer

November 30, 2018

Lung cancer is no longer a hopeless disease. In 2018 alone, there were eight Food and Drug Administration approvals for either new drugs or new indications to help treat non-small cell and small cell lung cancer.

An Afterthought Takes Center Stage

November 25, 2018

According to the National Comprehensive Cancer Network, a third of all people treated for cancer will have oral complications that may interfere with treatment or affect quality of life.

With Checkpoint Inhibitors Here to Stay, Patient Selection Has Become a Science of its Own

June 26, 2018

Checkpoint inhibitors — immunotherapy drugs that are improving the treatment landscape for many patients across the spectrum of cancers — are relatively new. The science involved in finding and treating the patients most likely to respond to these drugs — without overlooking any or treating those who won’t benefit — is even newer.